Biotest AG/ DE0005227235 /
| 13/03/2024 20:59:35 | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 30.4800USD | - | 200 Turnover: 5,926 |
-Bid Size: - | -Ask Size: - | 1.74 bill.USD | - | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -1.59 EUR | 103.85% |
| EPS Diluted: | -1.59 EUR | 103.85% |
| Revenues per Share: | 13.03 EUR | 6.48% |
| Book Value per Share: | 9.61 EUR | -13.86% |
| Cash Flow per Share: | 0.86 EUR | - |
| Dividend per Share: | 0.04 EUR | 0.00% |
| Total | in mill. | |
| Revenues: | 515.60 EUR | 6.48% |
| Net Income: | -63.40 EUR | 101.91% |
| Operating Cash Flow: | 33.90 EUR | - |
| Cash and Cash Equivalents: | 104.40 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 3.16 | 2.96 |
| P/BV ratio: | 4.29 | 4.02 |
| P/CF Ratio: | 48.09 | 45.06 |
| PEG: | -0.25 | - |
| Earnings Yield: | -3.86% | -4.12% |
| Dividend Yield: | 0.10% | 0.10% |
| Market Capitalization | ||
| Market Capitalization: | 1.74 bill. USD | 1.73 bill. USD |
| Free Float Market Cap.: | 869.47 mill. USD | 865.01 mill. USD |
| Market Cap. / Employee: | 442,030.7072 USD | 439,761.8052 USD |
| Shares Outstanding: | 19.79 mill. | |
Profitability
| Gross Profit Margin: | 15.65% |
| EBIT Margin: | -9.14% |
| Net Profit Margin: | -12.30% |
| Return on Equity: | -16.67% |
| Return on Assets: | -5.74% |
Financial Strength
| Liquidity I / Cash Ratio: | 98.12% |
| Liquidity II / Quick Ratio: | 198.97% |
| Liquidity III / Current Ratio: | 490.79% |
| Debt / Equity Ratio: | 190.27% |
| Dynam. Debt / Equity Ratio: | 2,135.10% |
Efficiency
| Employees: | 1,967 |
| Personal Expenses / Employee: | 83,019.83 EUR |
| Revenues / Employee: | 262,125.06 EUR |
| Net Income / Employee: | -32,231.83 EUR |
| Total Assets / Employee: | 561,362.48 EUR |
| * Fiscal Year End: | 31/12/2021 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
